PD-L2 Rabbit Polyclonal Antibody
To Order Contact Us Below:
PD-L2 Antibody |
4063-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PD-L2 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by co gnate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2, both of which are thought act as a negative regulator of T cell activation. However, it has been suggested that PD-L2 can act to stimulate an immunogenic response through and alternative receptor from PD-1. |
Anti-PD-L2 antibody |
STJ98748 |
St John's Laboratory |
200 µl |
EUR 236.4 |
Description: Rabbit polyclonal to PD-L2. |
PD-L2 Peptide |
4063P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (IN) PD-L2 peptide |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
A64216-020 |
EpiGentek |
20 ul |
EUR 117.7 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
A64216-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
A64216-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody |
A64216 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
PD-L2 Recombinant Protein |
91-721 |
ProSci |
0.05 mg |
EUR 821.4 |
Description: Programmed Cell Death 1 Ligand 2 (PDCD1LG2) is a member of the BTN/MOG family. PDCD1LG2 contains one Ig-like C2-type domain and one Ig-like V-type domain. PDCD1LG2 is highly expressed in the heart, placenta, pancreas, lung and liver; it is weakly expressed in the spleen, lymph nodes, and thymus. PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PDCD1LG2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
PD-L2 Recombinant Protein |
92-497 |
ProSci |
0.05 mg |
EUR 437.1 |
Description: Programmed cell death 1 ligand 2 (PD-L2), also known as butyrophilin B7-DC or PDCD1 ligand 2, belongs to the member of B7 family which can regulate the activation and tolerance of T cells. PD-L2 is one ligand for Programmed cell death 1(PD-1), and the other is PD-L1. These two ligands shares 34% aa sequence identity. Mouse PD-L2 gene encodes a 273 amino acids (aa) protein with a putative 19 aa signal peptide, a 201 aa extracellular region , a 21 aa transmembrane domain and a 32 aa cytoplasmic region. The mouse PD-L2 gene is highly expressed in heart, placenta, pancreas, lung and liver while expressed weakly in spleen, lymph nodes and thymus. Besides, the expression of PD-L2 gene can be induced on dendritic cells grown from peripheral blood mononuclear cells under CSF2 and IL4/interleukin-4 treatment, and up-regulated by IFNG/IFN-gamma stimulation in monocytes. PD-L2 usually functions in a PDCD1-independent manner and is involved in regulating costimulatory signal which is essential for T-cell proliferation and IFNG production. Recent studies demonstrate that the expression of PD-L2 on the tumor cells promotes CD8 T cell–mediated rejection of tumor cells, at both the induction and effector phase of antitumor immunity. Moreover, PD-L2 binds to PD-1 cells and enhances T cell killing in a PD-1–independent mechanism. |
PD-L2 Recombinant Protein |
96-938 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
PD-L2 Recombinant Protein |
97-021 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
PD-L2 Recombinant Protein |
97-022 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. |
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody |
20-abx319445 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ribosome-inactivating protein PD-L1/PD-L2 Antibody |
1-CSB-PA306294LA01PJJ |
Cusabio |
|
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, HRP Conjugated |
A64217-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, HRP Conjugated |
A64217-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, FITC Conjugated |
A64218-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, FITC Conjugated |
A64218-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, Biotin Conjugated |
A64219-050 |
EpiGentek |
50 ul |
EUR 302.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, Biotin Conjugated |
A64219-100 |
EpiGentek |
100 ul |
EUR 423.5 |
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, HRP Conjugated |
A64217 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, FITC Conjugated |
A64218 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Ribosome-Inactivating Protein PD-L1/PD-L2 Polyclonal Antibody, Biotin Conjugated |
A64219 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
PD-1:PD-L2 Homogeneous Assay Kit |
72015 |
BPS Bioscience |
384 rxns. |
EUR 1070 |
Description: The PD-1:PD-L2 Homogeneous Assay Kit is designed to measure the_x000D_inhibition of PD-1 binding to PD-L2. With this kit, only three simple steps on a microtiter_x000D_plate are required. First, a sample containing PD-1 and an inhibitor of choice is incubated with_x000D_the biotinylated PD-L2 for 60 minutes. Next, acceptor beads are added, then donor beads,_x000D_followed by reading the Alpha-counts. |
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (HRP) |
20-abx319446 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (FITC) |
20-abx319447 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody (Biotin) |
20-abx319448 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
CD273 [PD-L2] Recombinant Protein |
90-425 |
ProSci |
100 ug |
EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
CD273 [PD-L2] Recombinant Protein |
90-427 |
ProSci |
100 ug |
EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
CD273 [PD-L2] Recombinant Protein |
90-428 |
ProSci |
100 ug |
EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a costimulatory signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 (PD-L2) is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
PD-1:PD-L2 TR-FRET Assay Kit |
72012 |
BPS Bioscience |
384 rxns. |
EUR 1070 |
Description: The PD-1:PD-L2 TR-FRET Assay Kit is designed to measure the inhibition of PD-1 binding to_x000D_PD-L2 in a homogeneous 384 reaction format. Cell signaling through the PD-1 receptor upon_x000D_binding the PD-L2 ligand attenuates immune responses and is exploited by both tumors and_x000D_viruses. This FRET-based assay requires no time-consuming washing steps, making it_x000D_especially suitable for high throughput screening applications. The assay procedure is_x000D_straightforward and simple; a sample containing europium-labeled (Eu) PD-1, dye-labeled_x000D_acceptor, biotin-labeled PD-L2, and an inhibitor is incubated for two hours. Then, the_x000D_fluorescence intensity is measured using a fluorescence reader. |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody, HRP conjugated |
1-CSB-PA306294LB01PJJ |
Cusabio |
|
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is HRP conjugated. Tested in the following application: ELISA |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody, FITC conjugated |
1-CSB-PA306294LC01PJJ |
Cusabio |
|
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is FITC conjugated. Tested in the following application: ELISA |
Ribosome-inactivating protein PD-L1/PD-L2 Antibody, Biotin conjugated |
1-CSB-PA306294LD01PJJ |
Cusabio |
|
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2 |
1-CSB-EP306294PJJ |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Phytolacca dioica Ribosome-inactivating protein PD-L1/PD-L2 expressed in E.coli |
PD-1:PD-L2[Biotinylated] Inhibitor Screening Assay Kit |
72004 |
BPS Bioscience |
96 rxns. |
EUR 1095 |
Description: The PD-1:PD-L2[Biotinylated] Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-L2 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-1 is coated on a 96-well plate. Next, PD-L2 is incubated with PD-1 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader. |
PD-1[Biotinylated]:PD-L2 Inhibitor Screening Assay Kit |
72006 |
BPS Bioscience |
96 rxns. |
EUR 1235 |
Description: The PD-L2 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this signaling. The key to this kit is the high sensitivity of detection of biotin-labeled PD-1 by streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First, PD-L2 is coated on a 96-well plate. Next, PD-1 is incubated with PD-L2 on the plate. Finally, the plate is treated with streptavidin-HRP followed by addition of an HRP substrate to produce chemiluminescence, which can then be measured using a chemiluminescence reader. |
PD-1:PD-L1/PD-L2 Cell-Based Inhibitor Screening Assay Kit |
60800 |
BPS Bioscience |
96 rxns. |
EUR 1070 |
Description: The PD-1/PD-L1 Inhibitor Screening Cell-Based Assay is a bioluminescent cell-based assay that can be used to screen and profile inhibitors of PD-1:PD-L1 or PD-1:PD-L2 interaction. The assay consists of two main components:_x000D_ • PD-1 Effector cells (PD-1/NFAT reporter-Jurkat cells): Reporter Jurkat T cells expressing firefly luciferase gene under the control of NFAT response elements and also constitutively expressing human PD-1. These cryopreserved cells are provided in a thaw-and-use format that does not require cell propagation._x000D_ • _x000D_Expression vectors for TCR activator, human PD-L1, and human PD-L2: Transfection-ready vectors are used to transfect cells to create the target cells that overexpress PD-L1 or PD-L2 and an engineered cell surface T cell receptor (TCR) activator._x000D_ |
PD-L2 (CD273), Fc fusion (Human) |
71107 |
BPS Bioscience |
100 µg |
EUR 330 |
Description: Human secreted Programmed Death Ligand 2 (PD-L2)-Fc fusion protein, also known as CD273, PDCDL1G2, and B7-DC, GenBank Accession No. NM_025239, a.a. 20-219, fused at the C-terminus to the Fc portion of human IgG1 expressed in a HEK293 cell expression system. MW = 49 kDa. |
PD-1:PD-L2 Cell-Based Inhibitor Screening Assay Kit |
79378 |
BPS Bioscience |
96 rxns. |
EUR 615 |
Description: The PD-1/PD-L2 Inhibitor Screening Cell-Based Assay is a bioluminescent cell-based assay that can be used to screen and profile inhibitors of the PD-1:PD-L2 interaction. The assay consists of two main components:_x000D_• Growth-Arrested PD-1 Effector cells (PD-1/NFAT reporter-Jurkat cells): Reporter Jurkat T cells expressing firefly luciferase gene under the control of NFAT response elements and also constitutively expressing Human PD-1. These cryopreserved cells are provided in a thaw-anduse format that does not require cell propagation. These cells are modified not to be expanded and are intended to be used in a single experiment._x000D_• Expression vectors for TCR activator and Human PD-L2: Transfection-ready vectors are used to transfect cells to create the target cells that overexpress PD-L2 and an engineered cell surface T cell receptor (TCR) activator. |
PD-1:PD-L2[Biotinylated] Inhibitor Screening Colorimetric Assay Kit |
72017 |
BPS Bioscience |
96 rxns. |
EUR 1095 |
Description: Cell signaling through the PD-1 receptor upon binding the PD-L2 ligand_x000D_attenuates immune responses and is exploited by both tumors and viruses. The PD-1:PDL2[_x000D_Biotinylated] Inhibitor Screening Colorimetric Assay Kit is designed for screening inhibitors of_x000D_PD-L2 ligand binding to PD-1 receptor. The key to this kit is the high affinity of biotin-labeled PD-L2 for streptavidin-HRP._x000D_Only a few simple steps on a microtiter plate are required for the assay. First, PD-1 is coated on_x000D_a 96-well plate. Next, PD-L2 is incubated with PD-1 on the plate. Finally, the plate is treated with_x000D_streptavidin-HRP followed by addition of a colorimetric HRP substrate to produce color, which_x000D_can then be measured using a UV/Vis spectrophotometer microplate reader. |
PD-1[Biotinylated]:PD-L2 Inhibitor Screening Colorimetric Assay Kit |
72019 |
BPS Bioscience |
96 rxns. |
EUR 1095 |
Description: Cell signaling through the PD-1 receptor upon binding the PD-L2 ligand_x000D_attenuates immune responses and is exploited by both tumors and viruses. The PD-_x000D_1[Biotinylated]:PD-L2 Inhibitor Screening Colorimetric Assay Kit is designed for screening_x000D_inhibitors of PD-1 receptor binding to PD-L2 ligand. The key to this kit is the high affinity of biotin-labeled PD-1 for_x000D_streptavidin-HRP. Only a few simple steps on a microtiter plate are required for the assay. First,_x000D_PD-L2 is coated on a 96-well plate. Next, PD-1 is incubated with PD-L2 on the plate. Finally, the_x000D_plate is treated with streptavidin-HRP followed by addition of a colorimetric HRP substrate_x000D_substrate to produce color, which can then be measured using a UV/Vis spectrophotometer_x000D_microplate reader. |
Mouse Anti-Human CD273 (PD-L2) mAbConjugated Antibody |
CCM031 |
SAB |
100ul |
EUR 476.4 |
Anti-CD273/ PD-L2 Antibody [TY25], Unconjugated-100ug |
QAB101-100ug |
EnQuireBio |
100ug |
EUR 270 |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
R32447 |
NSJ Bioreagents |
100 ug |
EUR 419 |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V8176-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V8176-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V8176SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a protein of about 31kDa, which is identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V7546-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V7546-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V7546SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: PD-L2/PDCD1LG2 is involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProt] |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V7581-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V7581-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
PD-L2 Antibody / Programmed death ligand 2 / CD273 |
V7581SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a protein identified as PD-L2 (same as PDCD1LG2). Engagement of CD28 by B7-1 (CD80) or B7-2 (CD86) in the presence of antigen promotes T cell proliferation, cytokine production, differentiation of effector T cells and the induction of Bcl-x, a promoter of T cell survival. Conversely, engagement of CTLA4 by B7-1 or B7-2 may inhibit proliferation and IL-2 production. PD-L2 does not bind CD28, cytotoxic T lymphocyte A4 or ICOS (inducible co-stimulator). The constitutive expression of PD-L1 and PD-L2 on parenchymal cells of heart, lung and kidney suggests that the Pdcd-1-Pdcd-L system could provide unique negative signaling to help prevent autoimmune disease. |
L2 Polyclonal Antibody |
A56895-020 |
EpiGentek |
20 ul |
EUR 117.7 |
L2 Polyclonal Antibody |
A56895-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody |
A56895-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody |
A56907-020 |
EpiGentek |
20 ul |
EUR 117.7 |
L2 Polyclonal Antibody |
A56907-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody |
A56907-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody |
A56895 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
L2 Polyclonal Antibody |
A56907 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
CD273 [PD-L2] non-lytic Recombinant Protein |
90-426 |
ProSci |
100 ug |
EUR 651.3 |
Description: T cells require a signal induced by the engagement of the T cell receptor and a €œcostimulatory€ signal(s) through distinct T cell surface molecules for optimal T cell activation and tolerance. CD273 is one of two ligands for programmed death-1 (PD-1; CD279), a member of the CD28 family of immunoreceptors. The other identified ligand is PD-L1. CD273 is broadly expressed and also up regulated in a variety of tumor cell lines. On previously activated T cells, CD273 interaction with PD-1 inhibits TCR mediated proliferation and cytokine production, suggesting an inhibitory role in regulating immune responses. CD273 has a costimulatory function on resting T cells activated with suboptimal TCR signals. |
Mouse Anti-Human CD273 (PD-L2) mAb |
CM031-100ug |
SAB |
100ug |
EUR 250.8 |
Mouse Anti-Human CD273 (PD-L2) mAb |
CM031-25ug |
SAB |
25ug |
EUR 154.8 |
PD-L2, Fc Chimera (HEK293-expressed), Human |
HY-P7399 |
MedChemExpress |
50ug |
EUR 321.6 |
TranslationBlocker Human PD-L2/ CD273 siRNA, 10nmol |
QX8-10nmol |
EnQuireBio |
10nmol |
EUR 452.4 |
TranslationBlocker Human PD-L2/ CD273 siRNA, 2nmol |
QX8-2nmol |
EnQuireBio |
2nmol |
EUR 331.2 |
Recombinant PD-L2 Protein (Met1-Pro219) [His] |
VAng-Cr3818-100g |
Creative Biolabs |
100 µg |
EUR 973.2 |
Description: Recombinant PD-L2 Protein (Met1-Pro219) fused with a His tag at C-terminus was expressed in Mammalian cells, with a molecular weight of 40-45 kDa. (Uniprot ID: Q9BQ51) |
PD-L2 / TCR Activator Mammalian Expression Kit |
60620 |
BPS Bioscience |
500 rxns. |
EUR 565 |
Description: The recombinant expression vectors are designed to express human engineered T cell receptor (TCR) activator and human PD-L2 (GenBank Accession #NM_025239) in mammalian cells. The transfected cells can be used in conjunction with PD-1/NFAT Reporter/Jurkat T cells (BPS #60535) to study the interactions of PD-1 with PD-L2 ligand in a cellular context and screen for modulators of this signaling pathway._x000D_In this assay, PD-1/NFAT Reporter/Jurkat T cells are used as effector cells; HEK293 cells overexpressing PD-L1 (or PD-L2) and an engineered T cell receptor (TCR) activator are used as target cells. When these two cells are co-cultivated, TCR complexes on effector cells are activated by TCR activator on target cells, resulting in expression of the NFAT luciferase reporter. However, PD1 and PD-L1 or PD-L2 ligation prevents TCR activation and suppresses the NFAT-responsive luciferase activity. This inhibition can be specifically reversed by anti-PD1 or anti-PD-L1 antibodies. PD1, PD-L1, or PD-L2 neutralizing antibodies block PD1:PD-L1 and/or PD1:PD-L2 interaction and promote T cell activation, resulting in reactivation of the NFAT responsive luciferase reporter. |
Human PD-L2/B7-DC PicoKine ELISA Kit |
EK1447 |
BosterBio |
96 wells |
EUR 510 |
Description: For Quantitative Detection of human PD-L2 in cell culture supernates, serum and plasma (heparin, EDTA). |
ELISA kit for Human PD-L2/B7-DC |
EK5768 |
SAB |
96 tests |
EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human PD-L2/B7-DC in samples from serum, plasma, tissue homogenates and other biological fluids. |
Recombinant Mouse PD-L2/B7-DC/CD273 Protein |
RP00660 |
Abclonal |
10 μg |
EUR 174 |
Recombinant Human B7-DC/PD-L2/CD273 Protein |
RP00988 |
Abclonal |
10 μg |
EUR 186 |
Recombinant Human B7-DC/PD-L2/CD273 Protein |
RP00150 |
Abclonal |
20 μg |
EUR 231.6 |
Human CellExp? PD-L2 / B7-DC, mouse recombinant |
P1087-10 |
Biovision |
each |
EUR 170.4 |
Human CellExp? PD-L2 / B7-DC, mouse recombinant |
P1087-50 |
Biovision |
each |
EUR 548.4 |
PD-L2 / TCR activator - CHO Recombinant Cell Line |
79632 |
BPS Bioscience |
2 vials |
EUR 9400 |
Description: Recombinant CHO-K1 cells constitutively expressing human PD-L2 (Programmed Cell Death 1 Ligand 2 or CD273, GenBank accession #NM_025239) and an engineered T-cell receptor (TCR) activator. |
PD-L2 (CD273), Fc fusion, Biotin-labeled (Human) |
71108 |
BPS Bioscience |
50 µg |
EUR 440 |
Description: Human secreted Programmed Death Ligand 2 (PD-L2)-Fc fusion protein, also known as CD273, PDCDL1G2, and B7-DC, GenBank Accession No. NM_025239, a.a. 20-219, fused at the C-terminus to the Fc portion of human IgG1, with C-terminal Avitag ™ expressed in a HEK293 cell expression system and enzymatically biotinlabeled using Avi-tag™ technology. MW = 51 kDa. |
Polyclonal Apolipoprotein L2 Antibody |
APR05494G |
Leading Biology |
0.1ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Apolipoprotein L2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PIWI-L2 Antibody |
APR17843G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIWI-L2 . This antibody is tested and proven to work in the following applications: |
Polyclonal PIWI-L2 Antibody |
APR17844G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PIWI-L2 . This antibody is tested and proven to work in the following applications: |
PD-ECGF Polyclonal Antibody |
41799-100ul |
SAB |
100ul |
EUR 302.4 |
PD-ECGF Polyclonal Antibody |
41799-50ul |
SAB |
50ul |
EUR 224.4 |
PD-1 Polyclonal Antibody |
27584-100ul |
SAB |
100ul |
EUR 302.4 |
PD-1 Polyclonal Antibody |
27584-50ul |
SAB |
50ul |
EUR 224.4 |
PD-ECGF Polyclonal Antibody |
ABP53145-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of PD-ECGF from Human. This PD-ECGF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human PD-ECGF |
PD-ECGF Polyclonal Antibody |
ABP53145-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of PD-ECGF from Human. This PD-ECGF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human PD-ECGF |
PD-ECGF Polyclonal Antibody |
ABP53145-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of PD-ECGF from Human. This PD-ECGF antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human PD-ECGF |
Polyclonal PD-1 Antibody |
APR06440G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1 . This antibody is tested and proven to work in the following applications: |
Polyclonal PD-1 Antibody |
APR06441G |
Leading Biology |
0.1 mg |
EUR 790.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1 . This antibody is tested and proven to work in the following applications: |
PD-ECGF Polyclonal Antibody |
ES4144-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against PD-ECGF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
PD-ECGF Polyclonal Antibody |
ES4144-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against PD-ECGF from Human. This antibody is tested and validated for WB, ELISA, IHC, WB, ELISA |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
CJ99-10ug |
Novoprotein |
10ug |
EUR 120 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
CJ99-1mg |
Novoprotein |
1mg |
EUR 814.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
CJ99-500ug |
Novoprotein |
500ug |
EUR 589.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Recombinant Mouse PD-L2/B7-DC/CD273 (C-Fc) |
CJ99-50ug |
Novoprotein |
50ug |
EUR 230.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
Mouse Anti-Human CD273 (PD-L2), FITC Conjugated mAb |
CM032-100T |
SAB |
100T |
EUR 242.4 |
Mouse Anti-Human CD273 (PD-L2), FITC Conjugated mAb |
CM032-25T |
SAB |
25T |
EUR 181.2 |
Mouse Anti-Human CD273 (PD-L2), PE Conjugated mAb |
CM033-100T |
SAB |
100T |
EUR 494.4 |
Mouse Anti-Human CD273 (PD-L2), PE Conjugated mAb |
CM033-25T |
SAB |
25T |
EUR 242.4 |
Mouse Anti-Human CD273 (PD-L2), Biotin Conjugated mAb |
CM034-100ug |
SAB |
100ug |
EUR 416.4 |
Mouse Anti-Human CD273 (PD-L2), Biotin Conjugated mAb |
CM034-25ug |
SAB |
25ug |
EUR 224.4 |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
CW20-10ug |
Novoprotein |
10ug |
EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
CW20-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
CW20-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-mFC) |
CW20-50ug |
Novoprotein |
50ug |
EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
CA09-10ug |
Novoprotein |
10ug |
EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
CA09-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
CA09-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2/B7-DC/CD273 (C-6His) |
CA09-50ug |
Novoprotein |
50ug |
EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4038-100g |
Creative Biolabs |
100 µg |
EUR 1364.4 |
Description: Recombinant Human PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.3 kDa. (Accession ID: NP_079515.2) |
Recombinant Human PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4038-200g |
Creative Biolabs |
200 µg |
EUR 2024.4 |
Description: Recombinant Human PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.3 kDa. (Accession ID: NP_079515.2) |
Recombinant Cynomolgus PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4039-100g |
Creative Biolabs |
100 µg |
EUR 1364.4 |
Description: Recombinant Cynomolgus PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.6 kDa. (Accession ID: A4GW30) |
Recombinant Cynomolgus PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4039-200g |
Creative Biolabs |
200 µg |
EUR 2024.4 |
Description: Recombinant Cynomolgus PD-L2 Protein (Met1-Pro219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.6 kDa. (Accession ID: A4GW30) |
Recombinant Rat PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4040-100g |
Creative Biolabs |
100 µg |
EUR 1364.4 |
Description: Recombinant Rat PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.2 kDa. (Accession ID: NP_001101052.2) |
Recombinant Rat PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4040-200g |
Creative Biolabs |
200 µg |
EUR 2024.4 |
Description: Recombinant Rat PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.2 kDa. (Accession ID: NP_001101052.2) |
Recombinant Mouse PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4041-100g |
Creative Biolabs |
100 µg |
EUR 1232.4 |
Description: Recombinant Mouse PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.5 kDa. (Accession ID: Q9WUL5) |
Recombinant Mouse PD-L2 Protein (aa 1-219) [Fc] |
VAng-Cr4041-200g |
Creative Biolabs |
200 µg |
EUR 2024.4 |
Description: Recombinant Mouse PD-L2 Protein (Met1-Arg219) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.5 kDa. (Accession ID: Q9WUL5) |
Human CellExp? CD273 / B7-DC / PD-L2, human recombinant |
7369-10 |
Biovision |
each |
EUR 294 |
Human CellExp? CD273 / B7-DC / PD-L2, human recombinant |
7369-50 |
Biovision |
each |
EUR 836.4 |
Rat Anti-Mouse PD-L2 (B7-DC) Monoclonal antibody, clone TY25 |
CABT-L4293-1mg |
Creative Diagnostics |
1 mg |
EUR 1076.4 |
Rat Anti-Mouse PD-L2 (B7-DC) Monoclonal antibody, clone TY25 |
CABT-L4293-5mg |
Creative Diagnostics |
5 mg |
EUR 2886 |
PD-1 Rabbit pAb |
A11973-100ul |
Abclonal |
100 ul |
EUR 369.6 |
PD-1 Rabbit pAb |
A11973-200ul |
Abclonal |
200 ul |
EUR 550.8 |
PD-1 Rabbit pAb |
A11973-20ul |
Abclonal |
20 ul |
EUR 219.6 |
PD-1 Rabbit pAb |
A11973-50ul |
Abclonal |
50 ul |
EUR 267.6 |
PD-L1 Rabbit pAb |
A11273-100ul |
Abclonal |
100 ul |
EUR 369.6 |
PD-L1 Rabbit pAb |
A11273-200ul |
Abclonal |
200 ul |
EUR 550.8 |
PD-L1 Rabbit pAb |
A11273-20ul |
Abclonal |
20 ul |
EUR 219.6 |
PD-L1 Rabbit pAb |
A11273-50ul |
Abclonal |
50 ul |
EUR 267.6 |
PD-L1 Rabbit mAb |
A20270 |
Abclonal |
20 μL |
EUR 18 |
PD-L1 Rabbit mAb |
A20344 |
Abclonal |
20 μL |
EUR 18 |
PD-L1 Rabbit pAb |
A1645-100ul |
Abclonal |
100 ul |
EUR 369.6 |
PD-L1 Rabbit pAb |
A1645-200ul |
Abclonal |
200 ul |
EUR 550.8 |
PD-L1 Rabbit pAb |
A1645-20ul |
Abclonal |
20 ul |
EUR 219.6 |
PD-L1 Rabbit pAb |
A1645-50ul |
Abclonal |
50 ul |
EUR 267.6 |
L2 Polyclonal Antibody, HRP Conjugated |
A56896-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody, HRP Conjugated |
A56896-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody, FITC Conjugated |
A56897-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody, FITC Conjugated |
A56897-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody, Biotin Conjugated |
A56898-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody, Biotin Conjugated |
A56898-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody, HRP Conjugated |
A56908-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody, HRP Conjugated |
A56908-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody, FITC Conjugated |
A56909-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody, FITC Conjugated |
A56909-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody, Biotin Conjugated |
A56910-050 |
EpiGentek |
50 ul |
EUR 302.5 |
L2 Polyclonal Antibody, Biotin Conjugated |
A56910-100 |
EpiGentek |
100 ul |
EUR 423.5 |
L2 Polyclonal Antibody, HRP Conjugated |
A56896 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
L2 Polyclonal Antibody, FITC Conjugated |
A56897 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
L2 Polyclonal Antibody, Biotin Conjugated |
A56898 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
L2 Polyclonal Antibody, HRP Conjugated |
A56908 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
L2 Polyclonal Antibody, FITC Conjugated |
A56909 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
L2 Polyclonal Antibody, Biotin Conjugated |
A56910 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Polyclonal PD-1/PDCD1 Antibody |
APR00377G |
Leading Biology |
0.05ml |
EUR 580.8 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PD-1/PDCD1 . This antibody is tested and proven to work in the following applications: |
PD-1 Polyclonal Conjugated Antibody |
C27584 |
SAB |
100ul |
EUR 476.4 |
PD-ECGF Polyclonal Conjugated Antibody |
C41799 |
SAB |
100ul |
EUR 476.4 |
L2 Antibody |
1-CSB-PA356939LA01HMN |
Cusabio |
|
|
|
Description: A polyclonal antibody against L2. Recognizes L2 from Human papillomavirus type 18. This antibody is Unconjugated. Tested in the following application: ELISA |
L2 Antibody |
1-CSB-PA365848LA01HML |
Cusabio |
|
|
|
Description: A polyclonal antibody against L2. Recognizes L2 from Human papillomavirus type 16. This antibody is Unconjugated. Tested in the following application: ELISA |
Steady-Luc Firefly HTS Assay Kit (Lyophilized) |
30028-L2 |
Biotium |
1000TST |
EUR 732 |
Description: Minimum order quantity: 1 unit of 1000TST |
Minor Capsid Protein L2 (L2) Antibody |
20-abx317811 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Minor Capsid Protein L2 (L2) Antibody |
20-abx317815 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Rabbit AFP-L2 ELISA Kit |
ERTA0762 |
Abclonal |
96Tests |
EUR 625.2 |
Cleaved-Cathepsin L2 (L114) Polyclonal Antibody |
ABP50033-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of Cleaved-Cathepsin L2 L114) from Human, Monkey. This Cleaved-Cathepsin L2 L114) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cathepsin L2 at AA range: 70-150 |
Cleaved-Cathepsin L2 (L114) Polyclonal Antibody |
ABP50033-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of Cleaved-Cathepsin L2 L114) from Human, Monkey. This Cleaved-Cathepsin L2 L114) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cathepsin L2 at AA range: 70-150 |
Cleaved-Cathepsin L2 (L114) Polyclonal Antibody |
ABP50033-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of Cleaved-Cathepsin L2 L114) from Human, Monkey. This Cleaved-Cathepsin L2 L114) antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Cathepsin L2 at AA range: 70-150 |
Cleaved-Cathepsin L2 (L114) Polyclonal Antibody |
ES1032-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against Cleaved-Cathepsin L2 (L114) from Human/Monkey. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Cleaved-Cathepsin L2 (L114) Polyclonal Antibody |
ES1032-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against Cleaved-Cathepsin L2 (L114) from Human/Monkey. This antibody is tested and validated for WB, ELISA, WB, ELISA |
Recombinant Cynomolgus Programmed cell death ligand 2/PD-L2(C-Fc) |
CA92-10ug |
Novoprotein |
10ug |
EUR 187.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Cynomolgus Programmed cell death ligand 2/PD-L2(C-Fc) |
CA92-1mg |
Novoprotein |
1mg |
EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Cynomolgus Programmed cell death ligand 2/PD-L2(C-Fc) |
CA92-500ug |
Novoprotein |
500ug |
EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Cynomolgus Programmed cell death ligand 2/PD-L2(C-Fc) |
CA92-50ug |
Novoprotein |
50ug |
EUR 442.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Anti-PD-L1 (CD274) Rabbit Monoclonal Antibody |
M00109 |
BosterBio |
100ug/vial |
EUR 476.4 |
Description: Rabbit Monoclonal PD-L1 (CD274) Antibody. Validated in IHC-P, WB and tested in Human, Mouse, Rat. |
Anti-PD-1 (CD279), Rabbit Monoclonal Antibody |
A1825-50 |
Biovision |
each |
Ask for price |
Minor Capsid Protein L2 (L2) Antibody (HRP) |
20-abx317812 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Minor Capsid Protein L2 (L2) Antibody (FITC) |
20-abx317813 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Minor Capsid Protein L2 (L2) Antibody (Biotin) |
20-abx317814 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Minor Capsid Protein L2 (L2) Antibody (HRP) |
20-abx317816 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Minor Capsid Protein L2 (L2) Antibody (FITC) |
20-abx317817 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Minor Capsid Protein L2 (L2) Antibody (Biotin) |
20-abx317818 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
PIWI-L2 Antibody |
6569-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PIWI-L2 Antibody: PIWI-L2 is a member of the PIWI subfamily of Argonaute proteins, evolutionarily conserved proteins containing both PAZ and Piwi motifs that are crucial for the biogenesis and function of small non-coding RNAs and play important roles in stem cell self-renewal, RNA silencing, and translational regulation in diverse organisms. PIWI-L2 has been implicated in multiple roles including stem cell self-renewal and is highly expressed in many breast cancers. In these tumors, PIWI-L2 silences the expression of STAT3, a regulator of Bcl-XL and cyclin D1, allowing the proliferation and survival of breast cancer stem cells. Recent studies have shown that overexpression of PIWI-like proteins are potential biomarkers for colon and other cancers. |
PIWI-L2 Antibody |
6569-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PIWI-L2 Antibody: PIWI-L2 is a member of the PIWI subfamily of Argonaute proteins, evolutionarily conserved proteins containing both PAZ and Piwi motifs that are crucial for the biogenesis and function of small non-coding RNAs and play important roles in stem cell self-renewal, RNA silencing, and translational regulation in diverse organisms. PIWI-L2 has been implicated in multiple roles including stem cell self-renewal and is highly expressed in many breast cancers. In these tumors, PIWI-L2 silences the expression of STAT3, a regulator of Bcl-XL and cyclin D1, allowing the proliferation and survival of breast cancer stem cells. Recent studies have shown that overexpression of PIWI-like proteins are potential biomarkers for colon and other cancers. |
PIWI-L2 Antibody |
6031-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PIWI-L2 Antibody: PIWI-L2 is a member of the PIWI subfamily of Argonaute proteins, evolutionarily conserved proteins containing both PAZ and Piwi motifs that are crucial for the biogenesis and function of small non-coding RNAs and play important roles in stem cell self-renewal, RNA silencing, and translational regulation in diverse organisms. PIWI-L2 has been implicated in multiple roles including stem cell self-renewal and is highly expressed in many breast cancers. In these tumors, PIWI-L2 silences the expression of STAT3, a regulator of Bcl-XL and cyclin D1, allowing the proliferation and survival of breast cancer stem cells. Recent studies have shown that overexpression of PIWI-like proteins are potential biomarkers for colon and other cancers. |
PIWI-L2 Antibody |
6031-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PIWI-L2 Antibody: PIWI-L2 is a member of the PIWI subfamily of Argonaute proteins, evolutionarily conserved proteins containing both PAZ and Piwi motifs that are crucial for the biogenesis and function of small non-coding RNAs and play important roles in stem cell self-renewal, RNA silencing, and translational regulation in diverse organisms. PIWI-L2 has been implicated in multiple roles including stem cell self-renewal and is highly expressed in many breast cancers. In these tumors, PIWI-L2 silences the expression of STAT3, a regulator of Bcl-XL and cyclin D1, allowing the proliferation and survival of breast cancer stem cells. Recent studies have shown that overexpression of PIWI-like proteins are potential biomarkers for colon and other cancers. |
Apolipoprotein L2 antibody |
70R-50909 |
Fitzgerald |
100 ul |
EUR 292.8 |
Description: Purified Polyclonal Apolipoprotein L2 antibody |
PIWI-L2 Antibody |
25385-100ul |
SAB |
100ul |
EUR 468 |
PIWI-L2 Antibody |
25453-100ul |
SAB |
100ul |
EUR 468 |
Cyclin L2 Antibody |
20-abx116796 |
Abbexa |
|
|
|
Orail-L2 Antibody |
abx236005-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
KLK-L2 antibody |
70R-KR002 |
Fitzgerald |
100 ug |
EUR 360 |
Description: Affinity purified Rabbit polyclonal KLK-L2 antibody |
Rabbit Alpha fetoprotein L2 ELISA kit |
E04A0755-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Alpha fetoprotein L2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Alpha fetoprotein L2 ELISA kit |
E04A0755-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Alpha fetoprotein L2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Alpha fetoprotein L2 ELISA kit |
E04A0755-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Alpha fetoprotein L2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Apolipoprotein L2(APOL2) ELISA kit |
E04A1600-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Apolipoprotein L2(APOL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Apolipoprotein L2(APOL2) ELISA kit |
E04A1600-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Apolipoprotein L2(APOL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Apolipoprotein L2(APOL2) ELISA kit |
E04A1600-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Apolipoprotein L2(APOL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Cathepsin L2(CTSL2) ELISA kit |
E04C2168-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Cathepsin L2(CTSL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Cathepsin L2(CTSL2) ELISA kit |
E04C2168-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Cathepsin L2(CTSL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Cathepsin L2(CTSL2) ELISA kit |
E04C2168-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Cathepsin L2(CTSL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Cyclin L2(CCNL2) ELISA kit |
E04C1168-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Cyclin L2(CCNL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Cyclin L2(CCNL2) ELISA kit |
E04C1168-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Cyclin L2(CCNL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit Cyclin L2(CCNL2) ELISA kit |
E04C1168-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit Cyclin L2(CCNL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit hepsin L2(CTSL2) ELISA kit |
E04H0143-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit hepsin L2(CTSL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit hepsin L2(CTSL2) ELISA kit |
E04H0143-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit hepsin L2(CTSL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit hepsin L2(CTSL2) ELISA kit |
E04H0143-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rabbit hepsin L2(CTSL2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
PD-L1 Antibody |
49251-100ul |
SAB |
100ul |
EUR 399.6 |
PD-L1 Antibody |
49251-50ul |
SAB |
50ul |
EUR 286.8 |
PD-L1 Antibody |
4059-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
PD-L1 Antibody |
4059-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
PD-1 Antibody |
4065-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. |
PD-1 Antibody |
4065-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. |
PD-1 Antibody |
4067-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. |
PD-1 Antibody |
4067-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: PD-1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antig en-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PDL-1 and PDL-2. Upon binding to either of these ligands, signals generated by PD-1 inhibit the activation of the immune response in the absence of "danger signals" such as LPS or other molecules associated with bacteria or other pathogens. Evidence for this is seen in PD1-null mice who exhibit hyperactivated immune systems and autoimmune diseases. |
PD-1 Antibody |
24505-100ul |
SAB |
100ul |
EUR 468 |
PD-L2 Rabbit Polyclonal Antibody